Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 1998
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 1998
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2001
CompletedFirst Submitted
Initial submission to the registry
July 3, 2001
CompletedFirst Posted
Study publicly available on registry
July 5, 2001
CompletedJanuary 21, 2009
December 1, 2004
July 3, 2001
January 20, 2009
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-65 years of age.
- DSM IV diagnosis of schizophrenia or schizoaffective disorder.
- Competent to give informed consent.
- Previously participated in "Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome" Principal Investigator. Donna Wirshing, M.D.
You may not qualify if:
- Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent.
- History of substantial substance dependence 6 months prior to the study.
- Patients at high risk of suicide or other directed violence.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Greater Los Angeles Healthcare System
Los Angeles, California, 90073, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
Study Record Dates
First Submitted
July 3, 2001
First Posted
July 5, 2001
Study Start
April 1, 1998
Study Completion
March 1, 2001
Last Updated
January 21, 2009
Record last verified: 2004-12